Rhodiola Rosea: Clinical Evidence & Substantiation Summary
What Is Rhodiola Rosea?
Rhodiola rosea is an adaptogenic herb traditionally used in Scandinavian and Russian herbal medicine. Clinical research supports its effects on fatigue reduction, stress resilience, cognitive performance under stress, and exercise capacity.
Mechanism of action: Rhodiola modulates the HPA axis and influences monoamine neurotransmitters (serotonin, dopamine, norepinephrine). Its active compounds — rosavins and salidroside — inhibit MAO-A and COMT enzymes, enhancing catecholamine signalling. It also activates AMPK and has neuroprotective properties.
Clinical Evidence Summary
Below are 5 key clinical studies on Rhodiola Rosea. Nutra Comp analyses 28+ studies in its full clinical evidence report.
Rhodiola rosea for physical and mental fatigue: a systematic review
Population: 11 RCTs
Key finding: Rhodiola supplementation significantly reduced mental fatigue and improved cognitive function under stress conditions across multiple trials.
Stress management and the role of Rhodiola rosea
Population: 118 adults with burnout
Key finding: 400 mg/day of Rhodiola significantly improved burnout symptoms, emotional exhaustion, and stress perception after 12 weeks (p<0.01).
Rhodiola rosea supplementation and exercise performance
Population: 7 RCTs
Key finding: Rhodiola showed modest improvements in exercise endurance and perceived exertion, with stronger effects in untrained individuals.
A randomized trial of Rhodiola rosea for generalized anxiety disorder
Population: 80 participants with mild anxiety
Key finding: Rhodiola (200 mg twice daily for 14 days) significantly reduced self-reported anxiety, stress, anger, confusion, and depression scores vs. placebo.
Neuroprotective effects of Rhodiola rosea
Population: Multiple studies
Key finding: Salidroside demonstrated neuroprotective properties through antioxidant mechanisms and BDNF upregulation in human and preclinical studies.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for Rhodiola Rosea
Includes all 28+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is Rhodiola rosea FDA approved?
Rhodiola rosea is sold as a dietary supplement under DSHEA and does not require FDA approval. In Europe, it has a traditional herbal registration for temporary relief of stress symptoms.
What are the most studied benefits of Rhodiola?
The strongest evidence supports Rhodiola for reducing mental and physical fatigue, improving cognitive performance under stress, and supporting stress resilience. Evidence for exercise performance is modest but positive.
What dosage of Rhodiola is used in clinical studies?
Most studies use 200–600 mg/day of extract standardised to 3% rosavins and 1% salidroside. The SHR-5 extract is the most studied branded form.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist